Krystexxa Approval History
- FDA approved: Yes (First approved September 14th, 2010)
- Brand name: Krystexxa
- Generic name: pegloticase
- Dosage form: Injection
- Company: Savient Pharmaceuticals, Inc.
- Treatment for: Gout
Krystexxa (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
Development History and FDA Approval Process for Krystexxa
|Sep 15, 2010|| FDA Approves Krystexxa (pegloticase) for Gout|
|Mar 30, 2010||Savient Announces Krystexxa Resubmitted BLA Accepted for Review by the FDA|
|Mar 19, 2010||Savient Resubmits Biologics License Application for Krystexxa (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy|
|Sep 19, 2009||Savient Provides Update on Meeting with U.S. Food and Drug Administration for Krystexxa|
|Aug 4, 2009||Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Krystexxa|
|Jun 17, 2009||FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for Krystexxa for Refractory Chronic Gout|
|May 7, 2009||Savient Announces New Date for FDA Arthritis Advisory Panel Review of Krystexxa for Treatment Failure Gout|
|Feb 12, 2009||Savient Provides Update on Pegloticase BLA|
|Jan 28, 2009||Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients|
|Dec 30, 2008||Pegloticase BLA Filing Accepted for Priority Review by FDA|
|Oct 31, 2008||Savient Submits Biologics License Application (BLA) for Pegloticase|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.